Investor Highlights

Pharmaxis Announces First Sales of Aridol® in USA

Pharmaceutical research company Pharmaxis (ASX: PXS) today announced the first sales of its asthma diagnostic Aridol® (mannitol bronchial challenge test) in the United States following the relaunch of the product.

Read full media release - pdf

Proactive Investors Interview with Gary Phillips

Proactive Investors Interview with Pharmaxis Ltd CEO Gary Phillips on 23 November 2018.

Watch interview

Chairman's Address to 2018 Annual General Meeting

Chairman's Address by Malcolm McComas to the 2018 Annual General Meeting

Read full ASX announcement – pdf

CEO Presentation to 2018 AGM

Presentation by the Pharmaxis CEO and CFO to the 2018 AGM

View presentation – pdf

Investor Research Briefing Presentations

Presentations from the Investor Research Briefing held on 20 November 2018.

View presentation – pdf